Daily Briefing
Monday, August 24, 2026
What Changed
Pharma marketing's 2027 AI budget surge forces commercial teams to build answer-engine accountability before generative answers replace search as the primary clinical reference [1].
Industry & Products | Pharma marketers shift strategy toward answer engine optimization ahead of significant AI campaign budget allocations in 2027. In response to changing how healthcare professionals seek answers, pharma marketers are focusing most changes around answer engine optimization, with most teams planning to allocate a sizable portion of their budgets to AI campaigns by 2027 [1].
Medical Imaging | Interpretable deep learning system evaluated for three-stage focal liver lesion diagnosis on non-contrast MRI. An interpretable deep learning system for three-stage focal liver lesion diagnosis on non-contrast MRI was assessed in a multicenter, prospective study [2].
Medical Imaging | Regulatory Readiness Instrument maps 11 domains to 22-point rubric. The Regulatory Readiness Instrument for Medical Imaging AI (RRI-MI) provides a deployer-side readiness assessment framework that maps 11 governance domains onto a provisional 22-point ordinal readiness rubric, illustrated through a semiautonomous prostate cancer MRI case study [3].
Sources
- Pharma marketers need a share-of-answer strategy before AI spend · BioPharma Dive
- Interpretable deep learning for three-stage focal liver lesion diagnosis on non-contrast MRI: a multicenter, prospective study · npj Digital Medicine
- Deployer-side governance of medical imaging artificial intelligence: the regulatory readiness instrument (RRI-MI) for multi-jurisdictional and post-market compliance. · International journal of medical informatics
Daily healthcare AI brief
Get tomorrow's signal in your inbox
One concise briefing built from reporting, research, policy, blogs, videos, and full podcast transcripts.
Free. Already subscribed? Sign in to save and personalize.